SCHEMBL4044367

SCHEMBL4044367

CN(C)c1ccccc1C1(C(C(=O)NC2CCCCC2)C2CCCCC2)Nc2ccccc2N1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
POLB P06746 1/20 0.39
TSHR P16473 3/20 0.39
KMT2A Q03164 4/20 0.39
MEN1 O00255 3/20 0.39
HTT P42858 3/20 0.38
KDM4E B2RXH2 3/20 0.38
ALDH1A1 P00352 2/20 0.38
HPGD P15428 2/20 0.38
LMNA P02545 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HSD17B10 Q99714 2/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
GFER P55789 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4036690 0.84 TSHR (0.43) PKMSMN1; SMN2POLBTSHRKMT2A
SCHEMBL4039455 0.84 KMT2A (0.48) SMN1; SMN2POLBTSHRKMT2AMEN1
SCHEMBL4044962 0.83 KMT2A (0.49) SMN1; SMN2TSHRKMT2AMEN1HTT
SCHEMBL4042729 0.83 HPGD (0.44) SMN1; SMN2TSHRKMT2AMEN1HTT
SCHEMBL4044888 0.81 KMT2A (0.45) SMN1; SMN2POLBTSHRKMT2AMEN1
SCHEMBL4039869 0.81 HPGD (0.45) TSHRKMT2AMEN1ALDH1A1HPGD
SCHEMBL4043366 0.81 TSHR (0.50) SMN1; SMN2POLBTSHRKMT2AMEN1
SCHEMBL4042940 0.80 TSHR (0.45) SMN1; SMN2POLBTSHRKMT2AMEN1
SCHEMBL4044158 0.80 GAA (0.47) SMN1; SMN2POLBTSHRKMT2AMEN1
SCHEMBL4036736 0.80 LMNA (0.46) SMN1; SMN2POLBTSHRKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP disclosed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO disclosed